Pilot Study: Immune Checkpoints Polymorphisms in Greek Primary Breast Cancer Patients

Background: Breast cancer is the most prevalent and second leading cause of cancer-related death in women worldwide. Despite early detection and better treatment therapies, 30% of early-stage breast cancer patients still develop recurrent disease. Breast cancer is a heterogeneous disease comprising...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuol, Nyanbol, Yan, Xu, Barriga, Vanessa, Karakkat, Jimsheena, Vassilaros, Stamatis, Fyssas, Ioannis, Tsimpanis, Anastasios, Fraser, Sarah, Nurgali, Kulmira, Apostolopoulos, Vasso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405402/
https://www.ncbi.nlm.nih.gov/pubmed/36009373
http://dx.doi.org/10.3390/biomedicines10081827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405402/
https://www.ncbi.nlm.nih.gov/pubmed/36009373
http://dx.doi.org/10.3390/biomedicines10081827

Ejemplares similares